Moreover, BMP2 promotes bone metastasis of breast and prostate cancer via the AKT pathway, but BMP9 was shown to inhibit the AKT signaling in breast cancer and, thus, suppresses the formation of bone metastases. Here, GDF2 is linked to breast carcinoma.